Nisa Investment Advisors
TCRT icon

Nisa Investment Advisors’s Alaunos Therapeutics TCRT Stock Holding History

Nisa Investment Advisors’s Portfolio TCRT Stock Details TCRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-15
Closed -$5K – 2352
2020
Q3 		$5K Hold
15
– – ﹤0.01% 2199
2020
Q2 		$7K Hold
15
– – ﹤0.01% 1978
2020
Q1 		$5K Buy
15
+7
+88% +$3.62K ﹤0.01% 1955
2019
Q4 		$5K Hold
8
– – ﹤0.01% 1930
2019
Q3 		$5K Hold
8
– – ﹤0.01% 1906
2019
Q2 		$7K Hold
8
– – ﹤0.01% 1843
2019
Q1 		$4K Hold
8
– – ﹤0.01% 1945
2018
Q4 		$2K Hold
8
– – ﹤0.01% 1915
2018
Q3 		$4K Sell
8
-2
-20% -$858 ﹤0.01% 1903
2018
Q2 		$4K Hold
10
– – ﹤0.01% 1847
2018
Q1 		$6K Hold
10
– – ﹤0.01% 1776
2017
Q4 		$6K Hold
10
– – ﹤0.01% 1806
2017
Q3 		$9K Hold
10
– – ﹤0.01% 1762
2017
Q2 		$9K Hold
10
– – ﹤0.01% 1751
2017
Q1 		$9K Sell
10
-9
-47% -$8.38K ﹤0.01% 1713
2016
Q4 		$15K Hold
19
– – ﹤0.01% 1722
2016
Q3 		$16K Buy
19
+10
+111% +$8.04K ﹤0.01% 1722
2016
Q2 		$8K Hold
9
– – ﹤0.01% 1813
2016
Q1 		$10K Buy
+9
New +$9.21K ﹤0.01% 1778

Other funds holding TCRT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Nisa Investment Advisors's TCRT Position: Q4 2020 in Review

Nisa Investment Advisors sold out of Alaunos Therapeutics (TCRT) in Q4 2020, closing a stake of 15 shares — an estimated $5K sold.

Nisa Investment Advisors first reported a position in TCRT in Q1 2016 and held it in 19 quarters. The position peaked at $16K in Q3 2016. 156 funds tracked by Wall St. Rank hold TCRT as of Q4 2020.

  • Nisa Investment Advisors reported no remaining Alaunos Therapeutics position as of Q4 2020 after selling out during the quarter.
  • Nisa Investment Advisors sold 15 Alaunos Therapeutics shares in Q4 2020, an estimated $5K.
  • Nisa Investment Advisors first reported a position in Alaunos Therapeutics in Q1 2016 and held it in 19 quarters.
  • Nisa Investment Advisors's Alaunos Therapeutics position peaked at $16K in Q3 2016.
  • 156 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q4 2020.

Based on Nisa Investment Advisors's 13F filing for Q4 2020, filed 25 Jan 2021.